AVR · Company research
Anteris Technologies Global Corp. Common Stock (AVR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance | Anteris Technologies announced it has received full regulatory clearance from Germany's BfArM to initiate the PARADIGM Trial for its DurAVR Transcatheter Heart Valve in patients with severe aortic stenosis. The clearance enables patient recruitment at leading German centers and strengthens the trial's European expansion, as Germany represents Europe's largest TAVR market with extensive clinical infrastructure. | View source ↗ | GlobeNewswire Inc. | Oct 20, 2026 | bullish | 1 | 1 |
| Funds buy 272,695 Anteris Technologies (AVR) shares, with a resulting position of 6,358,271. - Stock Titan | Funds buy 272,695 Anteris Technologies (AVR) shares, with a resulting position of 6,358,271. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| (AVR) Risk Channels and Responsive Allocation - Stock Traders Daily | (AVR) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| Insider Stock Purchases: October 06, 2026 - Quiver Quantitative | Insider Stock Purchases: October 06, 2026 Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 6, 2026 | neutral | 0 | 0.6 |
| A 10% owner’s funds buy Anteris Technologies (AVR) shares on two October dates. - Stock Titan | A 10% owner’s funds buy Anteris Technologies (AVR) shares on two October dates. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVR Oct 2026 7.500 call (AVR261016C00007500) Stock Price, News, Quote & History - Yahoo! Finance Canada | AVR Oct 2026 7.500 call (AVR261016C00007500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 5, 2026 | neutral | 0 | 0.6 |
| AVR Nov 2026 2.500 call (AVR261120C00002500) Interactive Stock Chart - Yahoo! Finance Canada | AVR Nov 2026 2.500 call (AVR261120C00002500) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 3, 2026 | neutral | 0 | 0.6 |
| Anteris Technologies Global (Nasdaq:AVR) - Stock Analysis - Simply Wall Street | Anteris Technologies Global (Nasdaq:AVR) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Sep 29, 2026 | neutral | 0 | 0.6 |
| Anteris Extends Key Supply and Quality Agreement Term - The Globe and Mail | Anteris Extends Key Supply and Quality Agreement Term The Globe and Mail | View source ↗ | The Globe and Mail | Sep 24, 2026 | neutral | 0 | 0.6 |
| Anteris Technologies Enhances Executive Equity-Based Compensation Plans - The Globe and Mail | Anteris Technologies Enhances Executive Equity-Based Compensation Plans The Globe and Mail | View source ↗ | The Globe and Mail | Sep 18, 2026 | neutral | 0 | 0.6 |
| Insider Sale: 10% owner at $AVR Sells 174,721 Shares | AVR Stock News - Quiver Quantitative | Insider Sale: 10% owner at $AVR Sells 174,721 Shares | AVR Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 10, 2026 | neutral | 0 | 0.6 |
| Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - BioSpace | Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 BioSpace | View source ↗ | BioSpace | Aug 10, 2026 | neutral | 0 | 0.6 |
| AVR Forecast — Price Target — Prediction for 2027 - TradingView | AVR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Anteris Technologies Stock Looks Bullish If DurAVR's PARADIGM Delivers (NASDAQ:AVR) - Seeking Alpha | Anteris Technologies Stock Looks Bullish If DurAVR's PARADIGM Delivers (NASDAQ:AVR) Seeking Alpha | View source ↗ | Seeking Alpha | Apr 23, 2026 | neutral | 0 | 0.6 |
| Anteris Technologies Global Corp. Common Stock (AVR) Stock Price: Oct 8 Close $6.63 - Gotrade | Anteris Technologies Global Corp. Common Stock (AVR) Stock Price: Oct 8 Close $6.63 Gotrade | View source ↗ | Gotrade | Feb 5, 2026 | neutral | 0 | 0.6 |
| AVR Stock Pops Pre-Market: Medtronic Backs $200M Capital Raise To Fund Key Trial - Stocktwits | AVR Stock Pops Pre-Market: Medtronic Backs $200M Capital Raise To Fund Key Trial Stocktwits | View source ↗ | Stocktwits | Jan 21, 2026 | neutral | 0 | 0.6 |
| Medtronic to invest up to $90M in Anteris Technologies - MassDevice | Medtronic to invest up to $90M in Anteris Technologies MassDevice | View source ↗ | MassDevice | Jan 21, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.